These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 17334498)
41. Urokinase receptor variants in tissue and body fluids. Høyer-Hansen G; Lund IK Adv Clin Chem; 2007; 44():65-102. PubMed ID: 17682340 [TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307 [TBL] [Abstract][Full Text] [Related]
43. Evolving role of uPA/uPAR system in human cancers. Dass K; Ahmad A; Azmi AS; Sarkar SH; Sarkar FH Cancer Treat Rev; 2008 Apr; 34(2):122-36. PubMed ID: 18162327 [TBL] [Abstract][Full Text] [Related]
44. Structure and function of the urokinase receptor. Mondino A; Resnati M; Blasi F Thromb Haemost; 1999 Sep; 82 Suppl 1():19-22. PubMed ID: 10695480 [TBL] [Abstract][Full Text] [Related]
48. Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor. Nagase K; Kobayashi H; Yoshikawa E; Kurita N J Mol Graph Model; 2009 Aug; 28(1):46-53. PubMed ID: 19403319 [TBL] [Abstract][Full Text] [Related]
49. Expression of urokinase-type plasminogen activator and its receptor in keloids. Leake D; Doerr TD; Scott G Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1334-8. PubMed ID: 14676162 [TBL] [Abstract][Full Text] [Related]
50. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. Bonavaud S; Charrière-Bertrand C; Rey C; Leibovitch MP; Pedersen N; Frisdal E; Planus E; Blasi F; Gherardi R; Barlovatz-Meimon G J Cell Sci; 1997 May; 110 ( Pt 9)():1083-9. PubMed ID: 9175704 [TBL] [Abstract][Full Text] [Related]
51. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee. Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663 [TBL] [Abstract][Full Text] [Related]
52. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue. Bruse C; Radu D; Bergqvist A Mol Hum Reprod; 2004 Mar; 10(3):159-66. PubMed ID: 14981142 [TBL] [Abstract][Full Text] [Related]
54. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513 [TBL] [Abstract][Full Text] [Related]
55. Anthocyanidins inhibit migration of glioblastoma cells: structure-activity relationship and involvement of the plasminolytic system. Lamy S; Lafleur R; Bédard V; Moghrabi A; Barrette S; Gingras D; Béliveau R J Cell Biochem; 2007 Jan; 100(1):100-11. PubMed ID: 16823770 [TBL] [Abstract][Full Text] [Related]
56. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751 [TBL] [Abstract][Full Text] [Related]
57. Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism. Czekay RP; Loskutoff DJ J Cell Physiol; 2009 Sep; 220(3):655-63. PubMed ID: 19472211 [TBL] [Abstract][Full Text] [Related]
58. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts. Kiyan J; Smith G; Haller H; Dumler I Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446 [TBL] [Abstract][Full Text] [Related]
59. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793 [TBL] [Abstract][Full Text] [Related]